相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Importance of the cytomegalovirus seropositive recipient as a contributor to disease burden after solid organ transplantation
Vincent C. Emery et al.
JOURNAL OF CLINICAL VIROLOGY (2012)
Summary of the British Transplantation Society Guidelines for the Prevention and Management of CMV Disease After Solid Organ Transplantation
Peter A. Andrews et al.
TRANSPLANTATION (2011)
Primary CMV Infections Are Common in Kidney Transplant Recipients After 6 Months Valganciclovir Prophylaxis
I. Helantera et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients
A. Humar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Extended Valganciclovir Prophylaxis in D+/R- Kidney Transplant Recipients is Associated With Long-Term Reduction in Cytomegalovirus Disease: Two-Year Results of the IMPACT Study
Atul Humar et al.
TRANSPLANTATION (2010)
International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation
Camille N. Kotton et al.
TRANSPLANTATION (2010)
Prolonged Prophylaxis With Valganciclovir Is Cost Effective in Reducing Posttransplant Cytomegalovirus Disease Within the United States
Emily A. Blumberg et al.
TRANSPLANTATION (2010)
Cytomegalovirus in Solid Organ Transplant Recipients
A. Humar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
The 'Indirect' Effects of Cytomegalovirus Infection
R. B. Freeman
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Prospective follow-up of primary CMV infections after 6 months of valganciclovir prophylaxis in renal transplant recipients
Ilkka Helantera et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Valganciclovir for Cytomegalovirus Prevention in Solid Organ Transplant Patients: An Evidence-Based Reassessment of Safety and Efficacy
Andre C. Kalil et al.
PLOS ONE (2009)
CMV Mismatch Does Not Affect Patient and Graft Survival in UK Renal Transplant Recipients
Rachel J. Johnson et al.
TRANSPLANTATION (2009)
Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: Results of a randomized clinical trial
V. Kliem et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation
Supha K. Arthurs et al.
CLINICAL INFECTIOUS DISEASES (2008)
Donor and recipient CMV serostatus and antigenemia after renal transplantation: An analysis of 486 patients
David Hughes et al.
JOURNAL OF CLINICAL VIROLOGY (2008)
Delayed-onset primary cytomegalovirus disease after liver transplantation
Supha K. Arthurs et al.
LIVER TRANSPLANTATION (2007)
An assessment of interactions between hepatitis C virus and herpesvirus reactivation in liver transplant recipients using molecular surveillance
Atul Humar et al.
LIVER TRANSPLANTATION (2007)
Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis
Ajit P. Limaye et al.
TRANSPLANTATION (2006)
24-Week oral ganciclovir prophylaxis in kidney recipients is associated with reduced symptomatic cytomegalovirus disease compared to a 12-week course
AM Doyle et al.
TRANSPLANTATION (2006)
Cytomegalovirus infection in solid organ transplant recipients: New challenges and their implications for preventive strategies
Nina Singh
JOURNAL OF CLINICAL VIROLOGY (2006)
Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients
C Paya et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Late-onset cytomegalovirus disease in liver transplant recipients despite antiviral prophylaxis
AP Limaye et al.
TRANSPLANTATION (2004)
Definitions of cytomegalovirus infection and disease in transplant recipients
P Ljungman et al.
CLINICAL INFECTIOUS DISEASES (2002)
Evaluation of CMV viral load using Taqman™ CMV quantitative PCR and comparison with CMV antigenemia in heart and lung transplant recipients
M Guiver et al.
TRANSPLANTATION (2001)
Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity.
SB Boppana et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
